Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
5.10
+0.40 (8.51%)
At close: Mar 9, 2026, 4:00 PM EDT
5.00
-0.10 (-1.96%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Q32 Bio Employees
Q32 Bio had 43 employees as of December 31, 2024. The number of employees increased by 6 or 16.22% compared to the previous year.
Employees
43
Change (1Y)
6
Growth (1Y)
16.22%
Revenue / Employee
n/a
Profits / Employee
-$1,619,154
Market Cap
71.81M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 43 | 6 | 16.22% |
| Dec 31, 2023 | 37 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Adicet Bio | 152 |
| TScan Therapeutics | 148 |
| Fractyl Health | 101 |
| XBiotech | 88 |
| InflaRx | 74 |
| Annovis Bio | 15 |
| Cingulate | 13 |
| MediciNova | 13 |
QTTB News
- 19 days ago - Q32 Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference - PRNewsWire
- 20 days ago - Q32 Bio Announces $10.5 Million Registered Direct Offering - PRNewsWire
- 3 months ago - Dow Dips 200 Points; Q32 Bio Shares Jump - Benzinga
- 3 months ago - Why Is Small-Cap Q32 Bio Stock Soaring On Monday? - Benzinga
- 3 months ago - Q32 Bio Sells Complement Inhibitor ADX-097 - PRNewsWire
- 4 months ago - Q32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 4 months ago - Q32 Bio Announces Completion of Enrollment in Part B of SIGNAL-AA Phase 2a Clinical Trial of Bempikibart for Alopecia Areata - PRNewsWire
- 6 months ago - Q32 Bio to Participate in the 2025 Wells Fargo Healthcare Conference - PRNewsWire